Multimodal antidepressant vortioxetine increases frontal cortical oscillations unlike escitalopram and duloxetine - A quantitative EEG study in rats

Keyphrases

• Escitalopram 100%
• Duloxetine 100%
• Multimodal Antidepressants 100%
• Vortioxetine 100%
• EEG Study 100%
• Cortical Oscillations 100%
• Quantitative Electroencephalography (qEEG) 100%
• Ondansetron 27%
• Wakefulness 27%
• SB-269970 27%
• Occupancy 18%
• 5-HT3 18%
• 5-HT7 18%
• 5-HT1A Agonist 18%
• Oscillation 9%
• Positive Impact 9%
• Cortical Function 9%
• Receptor Antagonist 9%
• EEG Recording 9%
• Antagonism 9%
• Cortical Activity 9%
• 5-hydroxytryptamine 9%
• Cognitive Behavior 9%
• 5-HT Transporter 9%
• 5-HT1D Receptor 9%
• Partial Agonist 9%
• Transporter Inhibitor 9%
• Target Occupancy 9%
• In Vitro Autoradiography 9%
• 5-HT1A 9%
• 5-HT1B 9%
• Agonism 9%
• Awake Rat 9%
• REM Sleep 9%
• 5-HT7 Antagonist 9%
• Cortical Circuits 9%
• 5-HT3 Antagonist 9%
• Quantitative Spectral Analysis 9%
• Cognitive Metrics 9%
• Neuronal Oscillations 9%
• Clinical Impact 9%

Neuroscience

• Antidepressant 100%
• Vortioxetine 100%
• Escitalopram 100%
• Duloxetine 100%
• Flesinoxan 45%
• Wakefulness 27%
• Ondansetron 27%
• 5-HT1A Agonists 18%
• Behavior (Neuroscience) 9%
• Agonist 9%
• Receptor Antagonist 9%
• Serotonin Transporter 9%
• 5-HT1D Receptor 9%
• Autoradiograph 9%
• 5-HT3 Antagonist 9%